Michael J. Urban - 13 Feb 2026 Form 3 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
13 Mar 2026, 16:11:30 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Owen, Attorney-in-fact

Key filing fact

Michael J. Urban filed Form 3 for Werewolf Therapeutics, Inc. (HOWL) on 13 Mar 2026.

Key facts

  • This page summarizes Michael J. Urban's Form 3 filing for Werewolf Therapeutics, Inc. (HOWL).
  • 0 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2026, 16:11.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002118666 Primary reporting owner

Urban Michael J.

Relationship
VP of Finance & Corp. Contr.
Address
C/O WEREWOLF THERAPEUTICS, INC., 200 TALCOTT AVENUE, 2ND FLOOR, WATERTOWN
Signature
/s/ Jonathan Owen, Attorney-in-fact
Signature date
13 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HOWL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,284
Date
13 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HOWL holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
52,500
Exercise price
$3.65
Footnotes
F1
HOWL holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,365
Exercise price
$4.64
Footnotes
F2
HOWL holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$1.57
Footnotes
F3
HOWL holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
54,800
Exercise price
$1.56
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The option was granted on June 1, 2023. The shares underlying the option vested as to 25% on May 15, 2024, and the remainder vest in substantially equal monthly installments thereafter through May 15, 2027.

Footnote F2

The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.

Footnote F3

The option was granted on December 19, 2024, and is fully vested.

Footnote F4

The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .